TG THERAPEUTICS, INC. Other Current Assets
TG THERAPEUTICS, INC. (TGTX) had Other Current Assets of $43.90 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-05
- 2026-06-30: Other Assets, Current $43.90M.
- 2026-03-31: Other Assets, Current $51.46M.
- 2025-12-31: Other Assets, Current $57.58M.
- 2025-09-30: Other Assets, Current $55.85M.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $43.90M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $51.46M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $57.58M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $55.85M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $25.37M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $20.39M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $15.72M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $32.63M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $7.05M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $8.10M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $9.52M 10-K · filed 2025-03-03 | $5.34M 10-K · filed 2024-02-29 |
| 2023-09-30 | $12.08M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $11.09M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $4.46M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $2.36M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $2.95M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $3.14M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $4.02M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $2.88M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $2.50M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $2.95M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $4.80M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $1.08M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $641.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $1.54M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $1.94M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $611.00K 10-K · filed 2021-03-01 | |
| 2019-09-30 | $864.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $987.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $1.46M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $439.00K 10-K · filed 2020-03-02 | |
| 2018-09-30 | $526.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $816.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $978.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $437.00K 10-K · filed 2019-03-01 | $436.79K 10-K · filed 2018-03-15 |
| 2017-09-30 | $796.28K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $927.66K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $1.06M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $216.40K 10-K · filed 2018-03-15 | |
| 2016-09-30 | $500.56K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $649.74K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $730.52K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $308.33K 10-K · filed 2017-03-16 | |
| 2015-09-30 | $457.92K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $548.78K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $701.86K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $173.95K 10-K · filed 2016-03-15 | |
| 2014-09-30 | $258.72K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $197.85K 10-Q · filed 2014-07-24 | |
| 2014-03-31 | $359.88K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $47.80K 10-K · filed 2015-03-16 | |
| 2013-09-30 | $118.44K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $136.71K 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $225.44K 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $29.13K 10-K · filed 2014-03-07 | |
| 2012-09-30 | $64.65K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $89.49K 10-Q/A · filed 2012-09-07 | |
| 2012-03-31 | $79.03K 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $87.18K 10-K · filed 2013-03-21 | |
| 2011-09-30 | $100.76K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $116.83K 10-Q/A · filed 2011-09-14 | |
| 2010-12-31 | $141.62K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |